Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in ...

Roche has shared long-term phase 2 data on its BTK inhibitor fenebrutinib in relapsing multiple sclerosis (MS), providing evidence of durability over 96 weeks to build out its case ahead of the ...

Get access to the leaderboards pointing to tomorrow’s biggest stock movers. Roche Holdings AG RHHBY on Friday announced new 96-week data for fenebrutinib demonstrating that patients with ...

This was flattened out by flooding that left behind large erratics and ‘’roche moutonnee’’ which are lumps of bedrock, smoothed as the glacier went over the top of them. Queenstown Hill ...

The Roche family is offloading one of the most recognisable buildings in Rundle Mall following close to 80 years of ownership. The 1860s heritage-listed building, at the eastern end of the mall ...

Tiernan Power Roche continued his impressive form when steering Give Him A Chance to a first success in the 2m4f handicap hurdle. The jockey made it five winners in the last fortnight when scoring by ...

For the vice chairman and major shareholder of pharmaceutical powerhouse Roche, preserving nature is the only rational thing to do. Bucking the Trump-era zeitgeist, he means to persuade the ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

If, like me, SPF is a must-have in your skincare routine and La Roche Posay’s Invisible Fluid Suncream SPF50+ is your usual go-to, then I have the best next beauty buy for you. When browsing the ...

"For the first time, a PI3K pathway-targeted drug has shown it can help people with this breast cancer subtype live longer," said Levi Garraway, M.D., Ph.D., Roche's Chief Medical Officer and Head of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. "Itovebi exemplifies our continued commitment to improve survival rates for people with this common PIK3CA ...